Site Management Organization (Panthera Biopartners) launched its first clinical trials site in the UK. Based in Preston, in northern England, the new clinical investigational site is open for studies—independent Panthera Biopartners (Panthera) has three clinical trials already in the pipeline.
Panthera Biopartners Background
Founded by Dr. Ian Smith, founder of Synexus (the world’s largest SMO) in December 2018, he is one of the co-founders of the independently controlled SMO Panthera. The other co-founder is Professor John Lyon, who was previously a global executive at CRO Covance. The company is presently working on raising an “A” round of financing which they report in a press release will be concluded shortly. The SMO is presently recruiting a CEO.
The First Site
The first Panthera clinical investigational site is based in Preston, Lancashire, UK in October, 2019. More sites are planned in Glasgow and Rochdale in early 2020 with further sites under negotiation.
SMO Focus Area
SMO will expand its network of clinical investigational sites with the aim of recruiting patients and running clinical trials in therapy areas which are traditionally managed in primary care including cardiac disease, allergies, migraine, osteoarthritis, osteoporosis and diabetes. Additionally the company will expand into NASH, Neurology and Oncology into the new year.
Study Start up Expertise
The SMO brings considerable expertise in important areas such as study start up and site activation cycle times. For example, founding team members (and management) has extensive experience in patient recruitment and the conduct of clinical trials.
Call to Action: Interested in clinical investigational sites in the UK—connect with Panthera Biopartners.
Source URL: Read More
The public content above was dynamically discovered, by graded relevancy to this keyword domain, and was specifically filtered by “Creative Commons“ re-use licensing and/or by Press Release distributions. “Source URL” states the content’s owner and/or publisher. This site references the content above to generate its value-add, the dynamic sentimental analysis below, which allows us to research global sentiments across a multitude of topics related to this site’s specific keyword domain. Additionally, where applicable, this site references the content above to provide on-demand translations and to power its “Read Article to Me” feature, which reads the content aloud to visitors. Views expressed in the content above are solely those of the authors. We take content ownerships seriously: Click “DMCA” in site footer to request applicable content take-down.
Acquire this Domain
You can acquire this site’s domain name! We have nurtured its online marketing value by systematically curating this site by the domain’s relevant keywords. Explore our content network – you can advertise on each or rent vs. buy the domain. Buy@TLDtraders.com | Skype: TLDtraders | +1 (475) BUY-NAME (289 – 6263). Thousands search by this site’s exact keyword domain name! Most are sent here because search engines often love the keyword. This domain can be your 24/7 lead generator! If you own it, you could capture a large amount of online traffic for your niche. Stop wasting money on ads. Instead, buy this domain to gain a long-term marketing asset. If you can’t afford to buy then you can rent the domain.
We are Internet Investors, Developers, and Franchisers – operating a content network of several thousand sites while federating 100+ eCommerce and SaaS startups. With our proprietary “inverted incubation” model, we leverage a portfolio of $100M in valued domains to impact online trends, traffic, and transactions. We use robotic process automation, machine learning, and other proprietary approaches to power our content network. Contact us to learn how we can help you with your online marketing and/or site maintenance.